Free Cancer Report

Book Appointment with Dr Sudha Sinha in Hyderabad

Dr Sudha Sinha

Medical Oncologist

24 Years Exp. Hyderabad

Hematological Cancer

CARE Super Specialty Hospital & Transplant Centre, Banjara Hills, Hyderabad

24 years of experience

MBBS, MD (USA), DM (USA)

Hyderabad

600 / consultation

About Dr Sudha Sinha:

  • Dr Sudha Sinha is a practising Internal Medicine Physician and an Oncologist with an experience of 24 years.
  • She pursued her MBBS in the year 1996 from Gandhi Medical College, Hyderabad. She completed her Diplomate from the American Board of Internal Medicine in the year 2001 from American Board of Internal Medicine.

Education:

  • MBBS from Gandhi Medical College, University of Health Sciences, Hyderabad in (1996)
  • Intern in Internal Medicine at St. Barnabas Medical Center Livingston, NJ. USA from (1998 – 1999)
  • Resident in Internal Medicine at Barnabas Medical Center Livingston, NJ. USA from (1999- 2001)
  • Fellowship in Hematology and Oncology from Caritas St. Elizabeth's Medical Center Tufts University School of Medicine Boston, MA. USA from (2002 – 2005)
  • Chief Fellow, Division of Hematology/Oncology at Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA. USA from (2004-2005)

Experience:

  • Sinha Worked As Assistant Professor, Head of Department of Medical Oncology at MNJ Institute of Oncology and Regional Cancer Center, Hyderabad from 2007 To 2017 Established The Department of Medical Oncology Established The 60-Bed Adult Leukemia Program Established The 80 Pediatric Oncology Program Started The ICMR ( Indian Council of Medical Research) Funded Hospital Based National Cancer Registry Program Key Role in Expanding The Biochemistry, Microbiology and Pathology Labs at The Hospital She Also Worked As Senior Consultant in Hematology and Oncology at Continental Hospitals, Hyderabad from 2014 to 2017 She Worked As Senior Consultant Medical Oncologist at American Oncology Institute, Hyderabad from 2018 to 2020

Memberships:

  • European Society of Medical Oncology (ESMO)
  • Indian Medical Association (IMA)

Areas of interest:

  • Blood Cancer, Breast Cancer, Gynecological Cancer, Gestational Trophoblastic Disease.

Research publications:

  • Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM. Indian J Cancer. 2014 Apr-Jun;51(2):180-3. Efficacy of Rasburicase (Recombinant Urate Oxidase) In The Prevention And Treatment of Malignancy-Associated Hyperuricemia: An Indian Experience. Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha S, Satti V. Tumour Biol. 2015 May 10. [Epub Ahead Of Print]. Influence Of BCL2-938C >A And BAX-248G>A Promoter Polymorphisms In The Development of AML: Case-Control Study From South India Cingeetham A1, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. Asian Pac J Cancer Prev. 2015;16(7):2707-12. Role of The MDM2 Promoter Polymorphism (-309T>G) In Acute Myeloid Leukemia Development Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Mekkaw P, Annamaneni S, Digumarthi RR, Sinha S, Satti V.Tumour Biol. 2014 Sep;35(9):8813-22. Association of Caspase9 Promoter Polymorphisms With The Susceptibility of AML In South Indian Subjects. Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Tumour Biol. 2013 Dec 20. [Epub Ahead of Print]. Gelatinase B (- 1562C/T) Polymorphism In Tumor Progression And Invasion of Breast Cancer. Anuradha V, Anand BB, Suresh AV, Sinha S, Babu SC, Suresh K.Indian J Med Paediatr Oncol. 2013 Jan;34(1):11-5. Palliative Chemotherapy In Head And Neck Squamous Cell Cancer – What Is Best In Indian Population? A Time Without Symptoms, Treatment Toxicity Score Based Study. Attili SV, Ananda B, Mandapal T, Anjaneyulu V, Sinha S, Reddy OC. Gastrointest Cancer Res. 2011 Sep;4(5-6):173-7.Factors Influencing Progression- Free Survival In Gastrointestinal Stromal Tumors With Special Reference To Pathologic Features, Cytogenetics, And Radiologic Response. Suresh AV, Varma PP, Sinha S, Deepika S, Raman R, Srinivasan M, Mandapal T, Reddy CO, Anand BB. J Cancer Res Ther. 2010 Oct- Dec;6(4):448-51.Risk-Scoring System For Predicting Mucositis In Patients of Head and Neck Cancer Receiving Concurrent Chemoradiotherapy . Chirivella S, Rajappa S, Sinha S, Eden T, Barr RD. Indian J Pediatr. 2009 Dec;76(12):1231-Health-Related Quality of Life Among Children With Cancer In Hyderabad, India. Bala S, Kumar A, Soni S, Sinha S, Hanspal M.Biochem Biophys Res Commun. 2006 Apr 21;342(4):1040-8. Emp Is A Component of The Nuclear Matrix of Mammalian Cells And Undergoes Dynamic Rearrangements During Cell Division. Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R.J Clin Apher. 2006 Jul;21(2):116-20.Safety And Efficacy of Peripheral Blood Progenitor Cell Mobilization And Collection In Patients With Advanced Coronary Heart Disease

Papers & presentations:

  • Junior Investigator Award in recognition of the outstanding abstract submitted. 26th Annual Meeting of American Society of Apheresis 2005.
  • Resident Research Scholarship Award- St. Barnabas Medical Center. 2001
  • Civil Society Hall of Fame Award – 2015, New Delhi
  • Felicitation by Ladies Circle India – 2015
  • Young FICCI Ladies Organisation – Felicitation for Young Women Achievers building India– March 2012
  • Rotary Club of Bhagyanagar- Rotary Vocational Excellence Award– 2012
  • Rotary Club of Secunderabad- Award of Recognition – 2012
  • Unsung Heroines of Hyderabad- Recognition by Secunderabad Metropolitan Ladies Circle – 49 in 2014

Awards & recognition:

  • Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM. Indian J Cancer. 2014 Apr-Jun;51(2):180-3. Efficacy of rasburicase (recombinant urate oxidase) in the prevention and treatment of malignancy-associated hyperuricemia: an Indian experience.
  • Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha S, Satti V. Tumour Biol. 2015 May 10. [Epub ahead of print]. Influence of BCL2-938C >A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India
  • Cingeetham A1, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. Asian Pac J Cancer Prev. 2015;16(7):2707-12. Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid Leukemia development
  • Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Mekkaw P, Annamaneni S, Digumarthi RR, Sinha S, Satti V.Tumour Biol. 2014 Sep;35(9):8813-22. Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.
  • Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Tumour Biol. 2013 Dec 20. [Epub ahead of print]. Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of Breast Cancer.
  • Anuradha V, Anand BB, Suresh AV, Sinha S, Babu SC, Suresh K.Indian J Med Paediatr Oncol. 2013 Jan;34(1):11-5. Palliative Chemotherapy in head and neck squamous cell cancer – What is best in Indian population? A time without symptoms, treatment toxicity score based study.

Frequently asked questions:

Who is Dr Sudha Sinha?

Dr Sudha Sinha's educational qualifications include MBBS, MD (USA), DM (USA) . Dr Sudha Sinha is a member of European Society of Medical Oncology (ESMO) Indian Medical Association (IMA). Dr Sudha Sinha's areas of interest include Blood Cancer, Breast Cancer, Gynecological Cancer, Gestational Trophoblastic Disease..

Where does Dr Sudha Sinha practice?

Dr Sudha Sinha practices at CARE Super Specialty Hospital & Transplant Centre, Banjara Hills, Hyderabad; CARE Super Specialty Hospital, Hi tech City, Hyderabad

Why do patients visit Dr Sudha Sinha?

Patients frequently visit Dr Sudha Sinha for Blood Cancer, Breast Cancer, Gynecological Cancer, Gestational Trophoblastic Disease..

What is Dr Sudha Sinha's rating?

Dr Sudha Sinha is a highly rated Medical Oncologist with positive feedback from most patients treated.

What is Dr Sudha Sinha's education qualification?

Dr Sudha Sinha has the following qualifications: MBBS, MD (USA), DM (USA)

What does Dr Sudha Sinha specialize in?

Dr Sudha Sinha specializes as a Medical Oncologist with special interest in Blood Cancer, Breast Cancer, Gynecological Cancer, Gestational Trophoblastic Disease..

How many years of experience does Dr Sudha Sinha have?

Dr Sudha Sinha has an overall experience of 24 years as a Medical Oncologist.

How can I book an appointment with Dr Sudha Sinha?

You can book an appointment with Dr Sudha Sinha by clicking <>. We shall shortly confirm your booking upon receiving your request.

Specialisation

  • Blood Cancer, Breast Cancer, Gynecological Cancer, Gestational Trophoblastic Disease.